Literature DB >> 35245537

Mechanisms and pathogenesis of chronic rhinosinusitis.

Atsushi Kato1, Robert P Schleimer2, Benjamin S Bleier3.   

Abstract

Chronic rhinosinusitis (CRS) is a heterogeneous disease characterized by local inflammation of the upper airways and is historically divided into 2 main phenotypes: CRS with nasal polyps and CRS without nasal polyps. Inflammation in CRS is mainly characterized by 3 endotypes based on elevation of canonical lymphocyte cytokines: type (T) 1 (T1) by TH1 cytokine IFN-γ, T2 by TH2 cutokines IL-4, IL-5, and IL-13, and T3 by TH17 cytokines including IL-17. Inflammation in both CRS without nasal polyps and CRS with nasal polyps is highly heterogeneous, and the frequency of various endotypes varies geographically around the world. This finding complicates establishment of a unified understanding of the mechanisms of pathogenesis in CRS. Sinonasal epithelium acts as a passive barrier, and epithelial barrier dysfunction is a common feature in CRS induced by endotype-specific cytokines directly and indirectly. The sinonasal epithelium also participates in both innate immunity via recognition by innate pattern-recognition receptors and promotes and regulates adaptive immunity via release of chemokines and innate cytokines including thymic stromal lymphopoietin. The purpose of this review was to discuss the contribution of the epithelium to CRS pathogenesis and to update the field regarding endotypic heterogeneity and various mechanisms for understanding pathogenesis in CRS.
Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic rhinosinusitis; endotype; eosinophils; epithelial dysfunction; nasal polyps; neutrophils

Mesh:

Substances:

Year:  2022        PMID: 35245537      PMCID: PMC9081253          DOI: 10.1016/j.jaci.2022.02.016

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   14.290


  168 in total

1.  Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.

Authors:  Philippe Gevaert; Theodore A Omachi; Jonathan Corren; Joaquim Mullol; Joseph Han; Stella E Lee; Derrick Kaufman; Monica Ligueros-Saylan; Monet Howard; Rui Zhu; Ryan Owen; Kit Wong; Lutaf Islam; Claus Bachert
Journal:  J Allergy Clin Immunol       Date:  2020-06-07       Impact factor: 10.793

Review 2.  The effect of drugs and other compounds on the ciliary beat frequency of human respiratory epithelium.

Authors:  Alan D Workman; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2014 Nov-Dec       Impact factor: 2.467

3.  Nattokinase, profibrinolytic enzyme, effectively shrinks the nasal polyp tissue and decreases viscosity of mucus.

Authors:  Tetsuji Takabayashi; Yoshimasa Imoto; Masafumi Sakashita; Yukinori Kato; Takahiro Tokunaga; Kanako Yoshida; Norihiko Narita; Tamotsu Ishizuka; Shigeharu Fujieda
Journal:  Allergol Int       Date:  2017-04-04       Impact factor: 5.836

4.  Chronic airway inflammation provides a unique environment for B cell activation and antibody production.

Authors:  S Feldman; R Kasjanski; J Poposki; D Hernandez; J N Chen; J E Norton; L Suh; R G Carter; W W Stevens; A T Peters; R C Kern; D B Conley; B K Tan; S Shintani-Smith; K C Welch; L C Grammer; K E Harris; A Kato; R P Schleimer; K E Hulse
Journal:  Clin Exp Allergy       Date:  2017-01-26       Impact factor: 5.018

5.  Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease.

Authors:  Kathryn L Pothoven; James E Norton; Lydia A Suh; Roderick G Carter; Kathleen E Harris; Assel Biyasheva; Kevin Welch; Stephanie Shintani-Smith; David B Conley; Mark C Liu; Atsushi Kato; Pedro C Avila; Qutayba Hamid; Leslie C Grammer; Anju T Peters; Robert C Kern; Bruce K Tan; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2016-12-18       Impact factor: 10.793

6.  Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi.

Authors:  Seung-Heon Shin; Jens U Ponikau; David A Sherris; David Congdon; Evangelo Frigas; Henry A Homburger; Mark C Swanson; Gerald J Gleich; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

7.  Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.

Authors:  Vassili Soumelis; Pedro A Reche; Holger Kanzler; Wei Yuan; Gina Edward; Bernhart Homey; Michel Gilliet; Steve Ho; Svetlana Antonenko; Annti Lauerma; Kathleen Smith; Daniel Gorman; Sandra Zurawski; Jon Abrams; Satish Menon; Terri McClanahan; Rene de Waal-Malefyt Rd; Fernando Bazan; Robert A Kastelein; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

8.  TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells.

Authors:  Atsushi Kato; Silvio Favoreto; Pedro C Avila; Robert P Schleimer
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

Review 9.  Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.

Authors:  Robert P Schleimer
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

10.  Allergic inflammatory memory in human respiratory epithelial progenitor cells.

Authors:  Jose Ordovas-Montanes; Daniel F Dwyer; Sarah K Nyquist; Kathleen M Buchheit; Marko Vukovic; Chaarushena Deb; Marc H Wadsworth; Travis K Hughes; Samuel W Kazer; Eri Yoshimoto; Katherine N Cahill; Neil Bhattacharyya; Howard R Katz; Bonnie Berger; Tanya M Laidlaw; Joshua A Boyce; Nora A Barrett; Alex K Shalek
Journal:  Nature       Date:  2018-08-22       Impact factor: 49.962

View more
  1 in total

Review 1.  Therapeutic Strategies of Biologics in Chronic Rhinosinusitis: Current Options and Future Targets.

Authors:  Junhu Tai; Munsoo Han; Tae Hoon Kim
Journal:  Int J Mol Sci       Date:  2022-05-15       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.